ArticleInternational journal of biological sciences2022

Dysregulation of Transglutaminase type 2 through GATA3 defines aggressiveness and Doxorubicin sensitivity in breast cancer.

Gianluca Aguiari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.